Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott R Plotkin

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Current Opinion in Neurology|November 11, 2005
Update on primary central nervous system lymphomaScott R Plotkin
Neuro-Oncology|March 19, 2014
Chemoprevention for neurofibromatosis 2: just over the horizon?Scott R Plotkin
Seminars in Neurology|March 17, 2018
Neurofibromatosis and SchwannomatosisScott R Plotkin, Antje Wick
Reviews in Neurological Diseases|July 10, 2009
The Neurofibromatoses. Part 1: NF1Christine Lu-Emerson, Scott R Plotkin
Neurologic Clinics|April 15, 2003
Neurologic complications of cancer therapyScott R Plotkin, Patrick Y Wen
Advances in Experimental Medicine and Biology|March 14, 2012
NeurofibromatosesErik J Uhlmann, Scott R Plotkin
Reviews in Neurological Diseases|November 10, 2009
The neurofibromatoses. Part 2: NF2 and schwannomatosisChristine Lu-Emerson, Scott R Plotkin
Handbook of Clinical Neurology|October 6, 2025
Clinical epidemiology of NF2-related schwannomatosisD Gareth Evans, Scott R Plotkin
Neuro-Oncology|October 10, 2024
Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinibScott R Plotkin, Jaishri O Blakeley
Neurologic Clinics|October 30, 2007
Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromesChristopher J Farrell, Scott R Plotkin
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Current Opinion in Neurology|November 11, 2005
Update on primary central nervous system lymphomaScott R Plotkin
Neuro-Oncology|March 19, 2014
Chemoprevention for neurofibromatosis 2: just over the horizon?Scott R Plotkin
Seminars in Neurology|March 17, 2018
Neurofibromatosis and SchwannomatosisScott R Plotkin, Antje Wick
Reviews in Neurological Diseases|July 10, 2009
The Neurofibromatoses. Part 1: NF1Christine Lu-Emerson, Scott R Plotkin
Neurologic Clinics|April 15, 2003
Neurologic complications of cancer therapyScott R Plotkin, Patrick Y Wen
Advances in Experimental Medicine and Biology|March 14, 2012
NeurofibromatosesErik J Uhlmann, Scott R Plotkin
Reviews in Neurological Diseases|November 10, 2009
The neurofibromatoses. Part 2: NF2 and schwannomatosisChristine Lu-Emerson, Scott R Plotkin
Handbook of Clinical Neurology|October 6, 2025
Clinical epidemiology of NF2-related schwannomatosisD Gareth Evans, Scott R Plotkin
Neuro-Oncology|October 10, 2024
Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinibScott R Plotkin, Jaishri O Blakeley
Neurologic Clinics|October 30, 2007
Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromesChristopher J Farrell, Scott R Plotkin
Pageof 21